WilliamsJABansalAKKimBJ. Two thousand Blalock-Taussig shunts: a six-decade experience. Ann Thorac Surg. 2007;84(6):2070–2075.
2.
PetrucciOO’BrienSMJacobsMLJacobsJPManningPBEghtesadyP. Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg. 2011;92(2):642–651.
3.
AlsoufiBGillespieSMoriMClabbyMKanterKKogonB. Factors affecting death and progression towards next stage following modified Blalock-Taussig shunt in neonates. Eur J Cardiothorac Surg. 2016;50(1):169–177.
4.
PatregnaniJTSochetAAZurakowskiD. World J Pediatr Congenit Heart Surg. 2018; XX:XX-XX.
5.
Heidari-BateniGNorouziSHallMBrarAEghtesadyP. Defining the best practice patterns for the neonatal systemic-to-pulmonary artery shunt procedure. J Thorac Cardiovasc Surg. 2014;147(3):869–873.
6.
WesselDLBergerFLiJS; CLARINET Investigators. Clopidogrel in infants with systemic-to-pulmonary-artery shunts. N Engl J Med. 2013;368:2377–2384.
7.
EmaniSTrainorBZurakowskiD. Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. Thorac Cardiovasc Surg. 2014;148:810–816.
8.
EmaniSZurakowskiDMuloneMDiNardoJATrenorCC IIIEmaniSM. Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2017;154(5):1723–1730.
